Cheng, Y. (2025) “The Valuation and Strategic Role of Amgen as an Anchor Stock in the Biopharmaceutical Industry Under Market Volatility”, Journal of Innovation and Development, 13(1), pp. 294–300. doi:10.54097/am35dd94.